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Viruses and the cellular RNA
decay machinery
Marta Maria Gaglia and Britt A. Glaunsinger∗
The ability to control cellular and viral gene expression, either globally or
selectively, is central to a successful viral infection, and it is also crucial for
the host to respond and eradicate pathogens. In eukaryotes, regulation of message
stability contributes significantly to the control of gene expression and plays a
prominent role in the normal physiology of a cell as well as in its response
to environmental and pathogenic stresses. Not surprisingly, emerging evidence
indicates that there are significant interactions between the eukaryotic RNA
turnover machinery and a wide variety of viruses. Interestingly, in many cases
viruses have evolvedmechanisms not only to evade eradication by these pathways,
but also to manipulate them for enhanced viral replication and gene expression.
Given our incomplete understanding of howmany of these pathways are normally
regulated, viruses should be powerful tools to help deconstruct the complex
networks and events governing eukaryotic RNA stability.  2010 JohnWiley & Sons, Ltd.
WIREs RNA 2010 1 47–59
The virus–host interaction is akin to an evolution-ary arms race; viruses continually evolve and fine-
tune mechanisms to exploit the cellular machinery for
their own replication, while the host counter-attacks
using a multitude of strategies to detect and destroy
foreign invaders. Many such ‘molecular battles’ are
waged to control gene expression, as commandeering
this machinery is crucial to the success of all viral
infections. Given that the regulation of cellular gene
expression is orchestrated in large measure by changes
in messenger RNA (mRNA) stability, viruses must
interface with the cellular RNA decay pathways to
control the levels of cellular and viral RNAs. In addi-
tion, the cellular RNA destruction machinery likely
represents a formidable obstacle to viral genomic
and/or mRNA accumulation and integrity. Therefore,
while viral RNAs can be targeted for turnover by the
host machinery, in many cases viruses have evolved to
circumvent and even subvert these pathways to facil-
itate their own replication. This review will highlight
both these themes in relation to the variety of cellular
regulators and effectors controlling the ultimate fate of
RNA in an infected cell. We will focus on how viruses
are influenced by the basal mRNA decay machinery,
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as well as pathways governing mRNA quality control.
Although an extensive body of literature also exists
for microRNA and small interfering RNA-mediated
regulation of viral and cellular gene expression dur-
ing infection, this topic is reviewed elsewhere in this
journal and is thus not covered herein.
DEADENYLATION
Cellular mRNAs are protected at their termini
by a 5′ 7-methylguanosine cap and a 3′ non-
templated poly(A) tail, which facilitate translation and
restrict access of exonucleases. Within the nucleus,
deadenylases trim poly(A) tails for mRNA export
and participate in the destruction of non-coding or
aberrant transcripts.1 In the cytoplasm, poly(A) tail
removal is the first and often the rate-limiting step
of general mRNA turnover and is usually required
both for subsequent decapping and degradation of
the message body2 (Figure 1). Several deadenylase
complexes have been identified, including Ccr4-Caf1-
Not1, PAN2-PAN3, and PARN.3 While to date no
viruses have been shown to directly interfere with
specific deadenylases, several examples exist of viral
RNAs evading the general deadenylation process.
Alphaviruses such as Sindbis virus (SINV)
and Venezuelan equine encephalitis virus (VEEV)
are positive-sense single-stranded RNA [(+)RNA]
viruses whose genomic RNAs are both capped
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FIGURE 1 | Basal pathways of cellular mRNA decay. Degradation of
normal cellular mRNA initiates with removal of the poly(A) tail by one of
the cellular deadenylases. Subsequently, the Lsm1–7 protein complex
binds the 3′ untranslated region (UTR) of the deadenylated messages
and stimulates decapping by the Dcp2 enzyme and its activator protein
Dcp1. The message body is subject to 3′→5′ exonucleolytic decay by
the exosome or 5′→3′ decay by Xrn1.
and polyadenylated, resembling cellular mRNAs.
Consequently, to avoid degradation, SINV and
VEEV RNAs have evolved sequences that can
stall deadenylation4 (Figure 2(a)). A combination of
conserved sequences in the 3′ untranslated region
(UTR) of the viral genomes act in cis to repress
deadenylation in mosquito cell extracts, presumably
by mediating interaction with a protective cellular
factor.4 A 38-kDa mosquito protein binds both the
SINV and the VEEV 3′ UTRs and can be specifically
titrated away in the presence of excess viral UTR
sequences, leading to decreased viral RNA stability.
Interestingly, removal of the 38-kDa protein from
SINV RNA leads to increased binding of a 32-kDa
mosquito protein. This suggests a mechanism whereby
the viral UTRs may be stabilized by displacing
a deadenylation-promoting factor via preferential
binding to a protective factor. The identity of these
two cellular proteins and their conservation across
species is currently unknown. However, in the future
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FIGURE 2 | Viral circumvention or utilization of cellular
deadenylation and decapping pathways. (a) The RNAs of Sindbis virus
(SINV) and Venezuelan equine encephalitis virus (VEEV) contains
elements in the 3′ UTR that recruit a cellular 38-kDa protein and block
deadenylation, presumably by preventing binding of a 32-kDa
deadenylation-promoting factor. The PAN RNA of Kaposi’s
sarcoma-associated herpesvirus contains an element (ENE) that
interacts in cis with the poly(A) tail thus preventing deadenylase access.
(b) The RNA genomes of Brome mosaic virus (BMV) and hepatitis C
virus (HCV) can be bound by Lsm proteins in their 3′ and/or 5′ UTRs.
This enhances their translation, as well as facilitates replication,
possibly through recruitment of the RNAs to P bodies. Poxviruses
transcripts have polyadenine sequences within their 5′ UTRs, which
bind Lsm1–7. Lsm binding prevents decapping (and presumably 5′→3′
decay), as well as 3′→5′ degradation of the messages.
their characterization will likely provide insight both
into how both cellular mRNA deadenylation and viral
RNA stabilization are orchestrated.
A second mechanism of protection from dead-
enylation is used by a highly abundant non-coding
nuclear RNA of Kaposi’s sarcoma-associated her-
pesvirus (KSHV), termed PAN (Figure 2(a)). PAN
contains a 79-nt element (ENE) near its 3′ end that
acts post-transcriptionally to stabilize the RNA and
promote its nuclear retention.5 The ENE forms a
stem-loop structure containing a U-rich loop. This
loop makes intramolecular contacts with the PAN
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poly(A) tail and blocks deadenylation, presumably
in part by preventing access of deadenylases to the
RNA.6 However, a simple U-rich stretch is not suf-
ficient to recapitulate the effects of PAN-ENE,6 and
mutations in the stem region of PAN-ENE can also
abolish its function.7 These observations suggest that
the entire structure is required for efficient interac-
tion and potentially for the recruitment of additional
protective factors. As the function of PAN remains
unknown, at present the importance of the PAN-ENE
in KSHV infection cannot be assessed. The fact that
the decay kinetics of PAN are different from those
of cytoplasmic polyadenylated RNAs has led to the
speculation that PAN RNA degradation, particularly
at the stage of deadenylation, may be carried out by
a dedicated nuclear pathway that normally disposes
of incorrectly processed RNAs.6 Thus, the study of
PAN RNA protection from nuclear degradation may
provide information as to how polyadenylation and
deadenylation are carried out in the nucleus of mam-
malian cells and how they contribute to nuclear RNA
quality control.
THE Lsm COMPLEX
As deadenylation is completed, a ring-shaped hep-
tameric complex of Sm-like proteins (Lsm1–7) binds
to the 3′ end of the message and recruits the cel-
lular decapping enzymes Dcp1 and Dcp2, which
promote cap hydrolysis8–11 (Figure 1). The Lsm com-
plex is highly conserved in eukaryotes, and in yeast it
has been shown to associate with several additional
components of the RNA decay machinery, includ-
ing decapping activators and the 5′→3′ exonuclease
Xrn1.10–14 While the role of the Lsm proteins in
eukaryotes is closely linked to mRNA degradation,
several viruses use this complex instead to facilitate
viral replication and, surprisingly, to enhance viral
RNA stability.
The Lsm complex has been shown to participate
in both viral replication and translation of Brome
mosaic virus (BMV)15–17 and hepatitis C virus
(HCV)18 (Figure 2(b)). Like those of all other (+)RNA
viruses, the genomes of BMV and HCV are used first
as mRNAs for protein production, and subsequently
as templates for replication. These two processes
are considered mutually exclusive and often require
different cis-acting sequences. The genome of BMV
consists of three RNA segments that are 5′ capped,
but terminate in a 3′ tRNA-like structure rather than
a poly(A) tail. Although plants are its natural host,
BMV can also replicate in yeast, which has greatly
facilitated genetic dissection of host factors involved
in its replication cycle. A mutagenesis screen in yeast
identified Lsm1p as a host factor required for BMV
RNA replication.15 Subsequent studies showed that
Lsm1p, together with other components of the Lsm
complex, is also required for efficient BMV genomic
RNA translation elongation, but not initiation.17
While Lsm-stimulated BMV translation requires
multiple regions of the viral RNAs, the effect of Lsm
on BMV RNA replication is specifically dependent
on 3′ UTR elements.16,17 Thus, partially overlapping
signals appear to participate in the seemingly opposing
activities of translational enhancement and redirection
of RNAs from the translational pool into replication
complexes. Notably, Lsm proteins do not regulate
the translation of the BMV coat protein from a
fourth subgenomic RNA segment, RNA4, which is
generated during BMV replication, suggesting that
the effects of Lsm proteins on BMV RNA translation
and replication are tightly linked.17
As mentioned before, the Lsm complex is simi-
larly important for the HCV lifecycle, suggesting that
the observations on the role of Lsm in BMV replica-
tion and translation may generalize to many (+)RNA
viruses. Indeed, siRNA-mediated knockdown of Lsm1
and its co-activators PatL1 and Rck/p54 decreases
HCV intracellular RNA levels, translation, and viral
particle production.18 Using gel shift assays, the
Lsm1–7 ring was shown to interact with select HCV
5′ and 3′ UTR sequences necessary for translation
and replication, suggesting that it may play a direct
role in modulating these processes during infection.
It has been suggested that the Lsm proteins
may direct BMV RNAs to replication complexes
by recruiting them to P bodies, which are sites of
RNA storage and/or decay19 (Figure 2(b)). Because P
bodies are thought to hold mRNAs in a translationally
repressed state,20,21 in principle they could be ideal
sites for viral genome replication.19 Surprisingly,
when the BMV and HCV 3′ tRNA-like structure
are replaced with a poly(A) tail, the Lsm complex is
no longer required for viral RNA accumulation and
translation.16–18 One hypothesis is that these viruses
co-opt Lsm to compensate for the RNA stabilizing
functions normally provided by polyadenylation
and its associated poly(A) binding protein (PABP).
However, association with PABP should not result
in RNA recruitment to P bodies, as PABP is not a
component of P bodies.22 In addition, the mRNAs
associated with P bodies are generally believed to be
deadenylated.23 Therefore, it is not clear that PABP
and Lsm association could substitute for each other
in this system. Further studies are therefore needed to
delineate how and why the Lsm complex is required
for viral RNA replication only in the absence of
polyadenylation.
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Cellular Lsm proteins may also play a role in
the stability of mRNAs of poxviruses, which are
large DNA viruses that replicate in the cytoplasm
(Figure 2(b)). Transcripts from orthopoxviridae, par-
ticularly those expressed later in infection, often
contain non-templated adenosine stretches of 5–40
nucleotides within their 5′ UTRs, thought to be gener-
ated by polymerase stuttering.24 5′ adenosine tracts of
at least 10 nt were shown to promote mRNA stabiliza-
tion in cells and in cytoplasmic extracts by inhibiting
both decapping and 3′→5′ exonucleolytic decay of
the RNA.25 Although these adenosine stretches bind
PABP, titrating away PABP with excess poly(A) RNA
does not affect the stability of the 5′ adenosine tract-
containing transcripts. Their stabilization instead cor-
relates with direct binding of the Lsm1–7 complex.25
Poxviruses encode two decapping proteins, D9 and
D10, which contribute to the global cellular mRNA
turnover that occurs during poxvirus infection. How-
ever, D9/D10 can also target viral transcripts and may
restrict expression of early viral genes.26–28 Thus, Lsm
proteins may participate in the protection of late viral
messages from the viral decapping proteins, although
it has yet to be directly proven that this complex pro-
tects viral messages during infection or that it blocks
D9/D10 decapping activity.25
It is notable that the virus-associated roles of
the Lsm complex in mRNA stabilization, enhanced
translation, and replication are at odds with its
established cellular function in activating mRNA
decapping to facilitate message degradation. While it
is formally possible that these viruses are manipulating
the Lsm complex to induce novel activities, a more
likely explanation is that the Lsm proteins have
multifaceted roles in cellular gene expression, which
are being revealed and exploited by viruses.
5′→3′ mRNA DECAY
Decapping exposes the mRNA 5′ end, triggering rapid
exonucleolytic destruction of the message body pre-
dominantly via the 5′→3′ nuclease Xrn1 (Figure 1).
Viruses lacking a 5′ cap might therefore be par-
ticularly susceptible to Xrn1-mediated degradation.
Indeed, Xrn1 was initially discovered in the yeast
Saccharomyces cerevisiae for its ‘Superkiller’ (Ski)
phenotype: loss of Xrn1 resulted in cell death as a
consequence of increased levels of the toxin-encoding
uncapped M satellite double-stranded RNA (dsRNA)
of the L-A virus.29 In addition, both in yeast30 and
in the plant Nicotiana benthamiana,31 Xrn1 and its
homolog Xrn4 prevent the genomic RNA of Tomato
bushy stunt virus from accumulating (Figure 3(a)).
These exonucleases also reduce the levels of viral RNA
intermediates necessary for recombination, a process
that some RNA viruses exploit to repair their genomes
and increase diversity.32
How do RNA viruses avoid Xrn1-mediated
degradation? Some protect their RNAs by encoding
cis elements that can physically block Xrn1. The yeast
20S RNA narnavirus, for example, has a highly struc-
tured G-rich motif in its 5′ region that can block Xrn1
activity, thereby likely enhancing the 20S virus per-
sistence in yeast laboratory strains33 (Figure 3(b)). In
contrast, poliovirus (PV) recruits a ribonucleoprotein
(RNP) complex including poly(rC) binding proteins to
a 5′ cloverleaf RNA structure34 (Figure 3(b)). Muta-
tions in this structure and consequent loss of the RNP
adversely affect PV RNA stability, possibly as a conse-
quence of increasing susceptibility to Xrn1-mediated
degradation.35 This strategy is probably common to
many other members of the Picornaviridae family, as
the 5′ cloverleaf structure is highly conserved.36
Interestingly, some viruses instead exploit the
activity of Xrn1 (Figure 3(c)). Flaviviruses such as
West Nile and Dengue viruses may appropriate Xrn1
to produce a 3′ subgenomic RNA (termed sfRNA) that
plays an essential role in viral pathogenicity in both cell
culture and mice.37 These viruses have a highly struc-
tured sequence (stem loop II or SLII) within the 3′ UTR
of their genome that is necessary for the production
of the sfRNA. Depletion of Xrn1 prevents produc-
tion of sfRNA, suggesting that sfRNA is a product
of Xrn1-mediated degradation of the viral genomic
RNA upstream of SLII. In turn, this indicates that the
SLII element can stall Xrn1 activity. Because no other
Xrn1-blocking element has been described in mam-
malian cells, the SLII element will likely prove a valu-
able tool to study Xrn1-mediated degradation both in
the context of viral infections and in uninfected cells.
3′→5′ mRNA DECAY
The exosome, a multisubunit protein complex with
3′→5′ exonucleolytic activity, is the major driver
of RNA degradation from the 3′ end (Figure 1). In
the cytoplasm, this complex participates in mRNA
turnover after deadenylation, whereas in the nucleus
it plays an essential role in RNA processing and
quality control.38 Little is currently known about the
interaction of the exosome with viruses. However,
the zinc-finger antiviral protein (ZAP), an important
mediator of cellular response to retroviruses,39
alphaviruses,40 and filoviruses,41 has been shown to
bind the hRrp46 component of the exosome and
to recruit the complex to viral mRNAs to promote
their degradation.42 Depletion of the exosome using
siRNAs directed against the hRrp41 and hRrp46
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FIGURE 3 | Viral interactions with Xrn1. (a) During infection with Tomato bushy stunt virus, Xrn1 can prevent the accumulation of viral RNA and
of viral RNA intermediates that serve as substrates for recombination. (b) Some viruses prevent Xrn1 degradation of their uncapped genomic RNAs
(gRNA) by having highly structured sequences in the 5′ UTR, as in the case of 20S narnavirus, or by recruiting protein complexes to this region, as in
the case of Picornaviruses. (c) Flaviviral RNAs contain Xrn1 blocking sequences in their 3′ UTR. Xrn1-mediated degradation of the RNAs up to the
blocking sequence results in the generation of a functional subgenomic RNA, sfRNA.
subunits reduces turnover of reporter RNAs by
ZAP, suggesting that exosome activity is an integral
component of ZAP function. ZAP binds viral RNAs in
a sequence-specific manner, perhaps explaining why
this protein is not a broad-spectrum viral inhibitor.43
However, the absence of significant homology
between the various viral sequences bound by ZAP
implicates RNA structure as the primary determinant
for recognition. An important next step will be to
directly test whether exosome depletion rescues viral
replication defects in ZAP-expressing cells.
These findings suggest a role for the exosome
in controlling viral infection. In contrast, no evidence
currently exists for viruses directly co-opting this com-
plex. Nonetheless, given the widespread roles for the
exosome in RNA quality control and turnover, viruses
presumably activate this complex at least indirectly
when triggering turnover of cellular mRNAs. For
example, infection by select herpes and coronaviruses
results in a global destruction of host messages.44–48
The exosome, as well as other RNA turnover path-
ways, may contribute to degradation of full-length or
partially degraded mRNAs in these cases.
MRNA QUALITY CONTROL
Cells are equipped with specific mechanisms for
the recognition and disposal of defective mRNAs
generated by errors introduced during transcription
and RNA processing or as a result of mutations in the
DNA sequence. The best characterized of these path-
ways is nonsense-mediated decay (NMD), which tar-
gets mRNAs harboring a premature stop codon (PTC)
(Figure 4). The core NMD effectors are the Upf pro-
teins, which associate with prematurely terminating
mRNAs and trigger their rapid destruction. Current
models for NMD activation in human cells suggest
that Upf1 is recruited to these aberrant mRNAs during
the initial round of translation via interactions with
the eRF1 and eRF3 translation termination factors,
whereupon other effectors of NMD (including Upf2,
Upf3, and Smg proteins) join the complex.49 The aber-
rant mRNA is then cleaved endonucleolytically near
the PTC by the NMD factor Smg6, and the message
body is degraded by cellular exonucleases50,51 (Fig-
ure 4). Two features can mark mRNAs for destruction
via the NMD pathway. In human cells, one impor-
tant feature is the presence of exon–exon junctions
downstream of the termination codon, as determined
by the retention of exon-junction complexes (EJCs) at
these sites. Normally EJCs, which are deposited during
splicing, are displaced from the mRNA by translating
ribosomes.52–54 However, NMD can also occur in the
absence of splicing, suggesting that downstream EJCs
are not always required for activation of NMD.49
Indeed, a second determinant is the length of the 3′
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FIGURE 4 | Nonsense-mediated mRNA decay and mechanisms of viral avoidance. (a) When the translation machinery reaches the stop codon of a
normal mRNA, the eukaryotic release factors eRF1 and eRF3 are recruited to the ribosome, in part via interactions with PABP. This results in efficient
translation termination and re-initiation. (b) When mRNAs containing a premature stop codon (PTC) are translated, the presence of EJCs downstream
of the PTC, coupled with inefficient interactions between PABP and the termination factors, triggers nonsense-mediated decay (NMD). NMD is
induced by recruitment of Upf1–3 and the Smg proteins; cleavage by the endonuclease Smg6 triggers degradation of the mRNA fragments. Viruses
such as HIV-1 regulate the alterative splicing of their genomic RNAs to avoid the presence of EJCs downstream of stop codons. (c) The unspliced RNA
of Rous sarcoma virus has a very long 3′ UTR, which is stabilized by the RSE element that directly inhibits NMD. This element may artificially ‘shorten’
the 3′ UTR by making contacts with sequences close to the poly(A) tail.
UTR, which is monitored by the proximity of the
termination codon to the poly(A) tail. Messages bear-
ing PTCs possess longer 3′ UTRs than their wild-type
counterparts and this appears to decrease the efficiency
of translation termination and facilitate Upf1 recruit-
ment, even in the absence of downstream EJCs.55–57
NMD represents a potentially formidable obsta-
cle for viruses, many of which encode polycistronic
transcripts that would presumably be viewed by the
cellular NMD machinery as having aberrantly long 3′
UTRs. Additionally, viruses frequently use alternative
splicing to maximize coding potential, possibly creat-
ing spliced variants with EJC components remaining
downstream of the stop codon used by the 5′ ORF.
One way viruses may escape NMD is by tightly
regulating their splicing pattern, as is the case with
human immunodeficiency virus 1 (HIV-1).58 The sole
HIV-1 transcript is alternatively spliced to generate
more than 30 mRNAs. The genes are always spliced
out sequentially in a 5′→3′ order, so as to avoid gen-
erating transcripts where splicing of 3′ genes leads
to deposition of EJCs downstream of the termina-
tion codons of the 5′ genes. However, a consequence
of this strategy is that the 5′-most genes are gener-
ally translated from completely unspliced mRNAs,
which have very long UTRs between the stop codon
of the first gene and the poly(A) tail. Thus, some
viruses specifically avoid NMD by encoding pro-
tective elements within their long 3′ UTRs. This is
best illustrated by the avian retrovirus Rous sarcoma
virus (RSV), which contains a sequence element (RSE)
downstream of the Gag gene stop codon that pre-
vents the unspliced mRNA from being targeted for
degradation.59 Deletion of this sequence causes a dra-
matic shortening of the half-life of unspliced RSV
mRNA in a translation- and Upf1-dependent manner,
whereas insertion of the RSE protects PTC-containing
NMD substrates from degradation. Analyses of the
RSE structure using SHAPE chemistry and partial
RNase digestion indicate the presence of an AU-rich
stretch and stem-loop elements that are conserved
amongst 20 different avian retroviruses.60 While the
mechanisms by which the RSE blocks NMD remain
unknown, an intriguing preliminary observation sug-
gests that it may form an RNA–RNA interaction with
a region just upstream of the RSV poly(A) site.60
Given the correlation between the proximity of the
stop codon and poly(A) tail for NMD activation,
such an interaction could facilitate translation termi-
nation by bringing the poly(A) tail closer to the Gag
stop codon, thereby decreasing Upf1 recruitment (Fig-
ure 4). Alternatively, the RSE may bind proteins that
influence the stability of the mRNA.
It will be of interest to examine whether similar,
perhaps structurally related elements exist within
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other viral or cellular mRNAs with unusually long
3′ UTRs, as this may shed light on how this important
pathway is regulated normally in cells and in response
to infection. For example, both coronavirus and
SINV have long stretches of coding sequence at their
3′ end that are not translated from the genomic
mRNA, but instead are expressed from subgenomic
transcripts.61,62 During the translation of genes at the
5′ end of these viral genomes such sequences would
appear as very long 3′ UTRs, which might be predicted
to trigger NMD even in the absence of nuclear splicing
and EJC deposition. Thus, a protective mechanism
may be required to actively stabilize the RNA genomes
in such cases. A similar situation could arise during
infection with some DNA viruses such as those of
the gamma-herpesvirus subfamily, which transcribe a
number of potentially polycistronic messages.63
Additional, NMD-independent roles in viral
infection have been proposed for Upf1. For example,
Upf1 associates with HIV-1 RNA, and its presence
stabilizes the viral genome and facilitates translation
of the Gag precursor.64 These functions of Upf1 are
genetically separable from its role in NMD, as they are
observed even with mutants of the Upf1 RNA helicase
domain that have dominant-negative effects on NMD.
An intriguing idea is that cells may specifically
transform viral mRNAs into targets of quality control
pathways as an antiviral measure. Evidence for this
comes from studies with the pokeweed antiviral
protein (PAP), a ribosome-inactivating factor isolated
from the pokeweed plant Phytolacca americana that
functions via RNA depurination.65–67 This protein
has a broad-spectrum antiviral activity against both
plant and animal viruses, including HIV,68 and has
generated interest as a potential antiviral treatment.69
Although initially antiviral activity was ascribed to
the ribosome-inactivating function of PAP, it was
subsequently found that some of the PAP mutants
that are unable to depurinate ribosomal RNA (rRNA)
can still selectively inhibit viral replication.70 PAP was
subsequently shown to depurinate capped mRNAs,
and the aforementioned mutants were shown to retain
the ability to depurinate mRNAs.66 Recent studies
in yeast using BMV have shown that BMV RNAs
become depurinated upon PAP expression, leading
to ribosome stalling and enhanced RNA turnover71
(Figure 5). Interestingly, PAP-induced turnover of
BMV RNA did not occur in yeast defective in the
Dom34p endonuclease, a key component of a quality
control pathway termed No-go decay (NGD). NGD
is a surveillance mechanism that targets mRNAs
with translation-elongation stalls, for example as a
consequence of rare codons or strong secondary
structures. Following endonucleolytic cleavage by
M7Gppp Exosome
Xrn1
M7Gppp
Ribosomal stall
M7Gppp
Dom34p
M7Gppp
M7Gppp
PAP
Depurinated sitesRibosome
M7Gppp PAP
Brome mosaic virus RNA
FIGURE 5 | No-go decay (NGD) as an antiviral pathway. In yeast
ectopically expressing the plant protein PAP, the RNAs of Brome mosaic
virus are depurinated. This causes translating ribosomes to stall,
thereby triggering NGD via recruitment of the endonuclease Dom34p to
the translation complex. After Dom34p cleaves the RNA close to the site
of stalling, the resulting fragments become targets for exonucleases
such as Xrn1 and the exosome.
Dom34p, the resulting RNA fragments are degraded
from the 5′ end by the exonuclease Xrn1 and
from the 3′ end by the exosome72 (Figure 5). As
expected for NGD, yeast mutants defective in Xrn1
or exosome activity accumulate cleaved BMV RNA
intermediates.
While NGD has been demonstrated in yeast, an
analogous surveillance pathway in mammalian cells
has yet to be identified. Thus, it will be especially
interesting to determine whether PAP antiviral
activity against mammalian viruses similarly involves
depurination followed by translation-dependent RNA
turnover, as this would provide compelling evidence
for NGD in humans. Along these lines, a recent
study found a reduction in the RNA levels of
human T-cell leukemia virus type I (HTLV-I), as
well as viral RNA depurination, in mammalian cells
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that ectopically express PAP.73 However, unlike the
situation in yeast with BMV, HTLV-I RNAs were not
destabilized, arguing against an NGD-like mechanism
of suppression. It is noteworthy that whereas a
number of N-glycosidases that depurinate rRNA
have been described in plants,74 no such protein has
been reported in animal cells. In addition, it will be
important to elucidate which features differentiate
PAP-susceptible versus non-susceptible RNAs in light
of potential antiviral uses for PAP.
RNase L
In eukaryotic cells, endonucleases are critical com-
ponents of multiple cytoplasmic quality control
pathways but may not be major participants in
basal mRNA decay. However, an interferon-inducible
riboendonuclease, RNase L, has important roles in
the innate immune response to pathogens. RNase
L is activated in the presence of dsRNA, a
non-self species often present in virally infected cells
(Figure 6) (reviewed in Ref 75). dsRNAs stimulate
the activity of 2′,5′-oligoadenylate synthetase (OAS),
which produces the allosteric activator for RNase
L, 2′-5′-oligoadenylate (2–5A). Activated RNase L
cleaves at UU and UA dinucleotides and contributes
to the host defense by destroying not only viral
RNAs, but also cellular mRNAs and rRNAs that
are needed for viral replication, and by stimulating
apoptosis. In addition, cleavage by RNase L liber-
ates small dsRNA species that activate the pattern
recognition receptors RIG-I and Mda-5, leading to
IFN-β production and amplification of the antiviral
interferon response.76
dsRNA is most often found upon infection
with RNA viruses that produce dsRNA intermediates
during genome replication, although dsDNA viruses
can also produce dsRNA due to annealing of
complementary RNAs transcribed from opposite
strands of the genome. RNase L-deficient cells
and mice thus exhibit increased susceptibility to
infection by several viruses (reviewed in Ref 75)
including encephalomyocarditis virus,77 SINV,78 and
Coxsackievirus B4.79 It has also been proposed that
a human reduction-of-function mutation in RNase
L renders individuals more susceptible to xenotropic
murine leukemia-related virus, a retrovirus that has
been linked to prostate cancer and chronic fatigue
syndrome.80,81 A recent report has shown that in
the absence of RNase L, mice infected with a
neurotropic demyelinating strain of mouse hepatitis
virus (MHV) succumb to CNS encephalomyelitis.82
Notably, the infected RNase L-/- mice did not exhibit
increased neuronal infection, interferon induction,
or viral titers; mortality upon infection correlated
instead with advanced demyelination and CNS tissue
damage. Thus, RNase L somehow prevents extended
and sustained CNS tropism of MHV. The dramatic
effects of such subtle tropism alterations highlight
both the diversity of RNase L functions as well as its
complex interactions with infecting viruses.
Not surprisingly, many viruses have evolved
mechanisms to blunt the activation of RNase L, and
such inactivation occurs at a variety of different steps
in the RNase L pathway (Figure 6). The NS1 protein
of influenza A virus, for example, acts at a very
early step by coating dsRNA and thereby preventing
these species from activating OAS.83,84 Infection with
vaccinia virus (VV) or HIV-1, on the other hand,
dsRNA
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FIGURE 6 | Viruses interfere with several stages of the RNase L pathway. RNase L is indirectly activated by the presence of double-stranded RNA
(dsRNA) species in the cytoplasm of infected cells. dsRNA activates 2′,5′-oligoadenylate synthetase (OAS), which produces 2′-5′-oligoadenylate
(2–5A), an allosteric activator for RNase L (asterisks indicate active enzymes). The NS1 protein of influenza virus A prevents OAS activation, whereas
vaccinia virus and HIV-1 block activation of RNase L by 2–5A, the latter by decreasing the affinity of RNase L for its activator. Once activated, RNase L
can cleave viral RNAs and also cellular mRNAs and rRNAs. Several viruses specifically protect their RNAs from degradation, including poliovirus (PV),
hepatitis C virus (HCV), and possibly reoviruses, using their σ 3 protein. Reoviruses also exploit RNase L-mediated destruction of cellular messages to
decrease competition for gene expression machinery.
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potently induces 2–5A production, but subsequent
RNase L activation is blocked.75,85,86 In the case of
HIV-1, it appears that this is accomplished by some-
how decreasing the affinity of RNase L for 2–5A
(reviewed in Ref 85).
Some viruses, like HCV and PV, do not block
RNase L activation, but their RNAs still escape degra-
dation by this endonuclease. It has been shown that
select genotypes of HCV avoid RNase L cleavage by
suppressing the frequency of UU and UA sequences in
their genome, perhaps as a consequence of selective
evolutionary pressure.87 HCV genotypes in the human
population that are less sensitive to RNase L also show
increased interferon resistance.87 Conversely, the PV
genome is very UU/UA rich, but is still surprisingly
resistant to RNase L cleavage because of a structural
element present within the PV RNA2 ORF.88 This
element functions as a competitive inhibitor of RNase
L thereby directly blocking its enzymatic activity.89
The role of RNase L inhibition during PV infection
remains unclear, however, as PV carrying mutations
that prevent the formation of the inhibitory structural
element replicate to wild-type levels in cell culture, and
do not exhibit increased sensitivity to interferon.88
Although the above examples highlight RNase L
as an antiviral protein, in some cases it may facilitate
viral replication and/or dissemination. For example,
PV forms larger plaques if cultured in cells overex-
pressing wild-type RNase L, and smaller plaques in
cells overexpressing a dominant-negative form of the
protein.88 It has been hypothesized that PV selec-
tively inhibits RNase L early in infection, but then
uses RNase L-induced apoptosis to enhance viral
release and spread. Mammalian reoviruses may sub-
vert the host shutoff activity of RNase L to dispose
of cellular mRNAs and clear the gene expression
machinery for viral use.90 Replication of both the
Jones and Dearing reovirus strains was reduced by
∼1 log in RNase L knockout relative to wild-type
mouse embryo fibroblasts, supporting the idea that
the virus partially co-opts this pathway to facili-
tate infection.90 Interestingly, minimal degradation of
rRNAs was observed, suggesting that RNase L may
not act indiscriminately as originally thought, but
rather target specific sequences.91–93 The mechanism
of viral escape from these pathways remains unknown,
although the reovirus σ3 protein has been proposed
to coat viral dsRNAs, thereby selectively inhibiting
RNase L activation in cytoplasmic locales where viral
RNA replication occurs, i.e., ‘replication factories’.94
However, it should be noted that the results men-
tioned above contrast with earlier findings implicating
RNase L in restricting reovirus replication, which
may be due to the use of different cell types in these
studies.95,96
PERSPECTIVES
In addition to the examples highlighted herein, in
many other cases viral infection presumably leads
to robust engagement of cellular mRNA turnover
machinery. For example, several viruses remove the
7-methylguanosine caps from cellular mRNAs, pre-
vent appropriate cellular mRNA splicing, 3′ process-
ing, or polyadenylation, or directly cleave cellular
messages.27,46,97–100 Presumably these events lead
to destruction of the impaired cellular transcripts
through both basal and quality control machinery
operating in the nucleus and in the cytoplasm. Such
elevated global RNA degradation may overload the
RNA turnover machinery, potentially indirectly sta-
bilizing viral transcripts. Aside from affecting global
RNA levels, viruses can also selectively alter the sta-
bility of specific messages through the induction of
cellular signaling pathways. For example, the acti-
vation of the MK2/p38 pathway by the kaposin B
protein of KSHV leads to stabilization of cytokine
mRNAs bearing AU-rich elements in their 3′ UTRs.101
In these cases, viral manipulation of select transcript
stability likely has important consequences for overall
pathogenesis.
Our understanding of the multitude of ways in
which viruses either commandeer or are controlled
by cellular mRNA turnover pathways is constantly
evolving, and far from complete. Moreover, many
of the pathways governing cellular mRNA decay
remain incompletely understood even in uninfected
cells, and new components and mechanisms are con-
stantly described. Thus, as in many other fields of
biology, viruses will continue to be invaluable tools
for revealing key modulators of mRNA stability and
destruction both in normal and pathogenic states.
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